Wednesday, March 6, 2024
Home Tags ETEC


Immuron prepares for diarrhoea-focused clinical trial as US FDA lifts clinical hold

Immuron, an Australia-based biopharmaceutical company, is slated to move forward with the clinical evaluation of a new oral therapeutic targeting Campylobacter and Enterotoxigenic Escherichia coli (ETEC) following approval from the US Food and Drug Administration (FDA).

Australian Weighing Equipment

Zenko Energy


Featured Article

The Intelligent Manufacturing Forum: Automation pathways for Australian manufacturers

The Australian manufacturing sector is navigating increasingly rapid changes in industry dynamics as more technological advancements are adopted worldwide.